R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers
Abstract Background Estrogen receptor α (ESR1) plays a critical role in promoting growth of various cancers. Yet, its role in the development of pancreatic cancer is not well-defined. A less studied region of ESR1 is the hinge region, connecting the ligand binding and DNA domains. rs142712646 is a r...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07005-x |
id |
doaj-23fbffe0bc4e4f68b8422de0123da267 |
---|---|
record_format |
Article |
spelling |
doaj-23fbffe0bc4e4f68b8422de0123da2672020-11-25T03:38:26ZengBMCBMC Cancer1471-24072020-06-0120111510.1186/s12885-020-07005-xR269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancersTomer Boldes0Keren Merenbakh-Lamin1Shani Journo2Eliya Shachar3Doron Lipson4Adva Yeheskel5Metsada Pasmanik-Chor6Tami Rubinek7Ido Wolf8Institute of Oncology, Tel Aviv Sourasky Medical CenterInstitute of Oncology, Tel Aviv Sourasky Medical CenterInstitute of Oncology, Tel Aviv Sourasky Medical CenterInstitute of Oncology, Tel Aviv Sourasky Medical CenterFoundation Medicine, Inc.The Bioinformatics Unit, George S. Wise Faculty of Life Sciences, Tel Aviv UniversityThe Bioinformatics Unit, George S. Wise Faculty of Life Sciences, Tel Aviv UniversityInstitute of Oncology, Tel Aviv Sourasky Medical CenterInstitute of Oncology, Tel Aviv Sourasky Medical CenterAbstract Background Estrogen receptor α (ESR1) plays a critical role in promoting growth of various cancers. Yet, its role in the development of pancreatic cancer is not well-defined. A less studied region of ESR1 is the hinge region, connecting the ligand binding and DNA domains. rs142712646 is a rare SNP in ESR1, which leads to a substitution of arginine to cysteine at amino acid 269 (R269C). The mutation is positioned in the hinge region of ESR1, hence may affect the receptor structure and function. We aimed to characterize the activity of R269C-ESR1 and study its role in the development of pancreatic cancer. Methods Transcriptional activity was evaluated by E2-response element (ERE) and AP1 –luciferase reporter assays and qRT-PCR. Proliferation and migration were assessed using MTT and wound healing assays. Gene-expression analysis was performed using RNAseq. Results We examined the presence of this SNP in various malignancies, using the entire database of FoundationOne and noted enrichment of it in a subset of pancreatic non-ductal adenocarcinoma (n = 2800) compared to pancreatic ductal adenocarcinoma (PDAC) as well as other tumor types (0.53% vs 0.29%, p = 0.02). Studies in breast and pancreatic cancer cells indicated cell type-dependent activity of ESR1 harboring R269C. Thus, expression of R269C-ESR1 enhanced proliferation and migration of PANC-1 and COLO-357 pancreatic cancer cells but not of MCF-7 breast cancer cells. Moreover, R269C-ESR1 enhanced E2-response elements (ERE) and AP1-dependent transcriptional activity and increased mRNA levels of ERE and AP1-regulated genes in pancreatic cancer cell lines, but had a modest effect on MCF-7 breast cancer cells. Accordingly, whole transcriptome analysis indicated alterations of genes associated with tumorigenicity in pancreatic cancer cells and upregulation of genes associated with cell metabolism and hormone biosynthesis in breast cancer cells. Conclusions Our study shed new light on the role of the hinge region in regulating transcriptional activity of the ER and indicates cell-type specific activity, namely increased activity in pancreatic cancer cells but reduced activity in breast cancer cells. While rare, the presence of rs142712646 may serve as a novel genetic risk factor, and a possible target for therapy in a subset of non-ductal pancreatic cancers.http://link.springer.com/article/10.1186/s12885-020-07005-xPancreatic cancerEstrogen receptorActivation Function-1SNP |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tomer Boldes Keren Merenbakh-Lamin Shani Journo Eliya Shachar Doron Lipson Adva Yeheskel Metsada Pasmanik-Chor Tami Rubinek Ido Wolf |
spellingShingle |
Tomer Boldes Keren Merenbakh-Lamin Shani Journo Eliya Shachar Doron Lipson Adva Yeheskel Metsada Pasmanik-Chor Tami Rubinek Ido Wolf R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers BMC Cancer Pancreatic cancer Estrogen receptor Activation Function-1 SNP |
author_facet |
Tomer Boldes Keren Merenbakh-Lamin Shani Journo Eliya Shachar Doron Lipson Adva Yeheskel Metsada Pasmanik-Chor Tami Rubinek Ido Wolf |
author_sort |
Tomer Boldes |
title |
R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers |
title_short |
R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers |
title_full |
R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers |
title_fullStr |
R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers |
title_full_unstemmed |
R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers |
title_sort |
r269c variant of esr1: high prevalence and differential function in a subset of pancreatic cancers |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2020-06-01 |
description |
Abstract Background Estrogen receptor α (ESR1) plays a critical role in promoting growth of various cancers. Yet, its role in the development of pancreatic cancer is not well-defined. A less studied region of ESR1 is the hinge region, connecting the ligand binding and DNA domains. rs142712646 is a rare SNP in ESR1, which leads to a substitution of arginine to cysteine at amino acid 269 (R269C). The mutation is positioned in the hinge region of ESR1, hence may affect the receptor structure and function. We aimed to characterize the activity of R269C-ESR1 and study its role in the development of pancreatic cancer. Methods Transcriptional activity was evaluated by E2-response element (ERE) and AP1 –luciferase reporter assays and qRT-PCR. Proliferation and migration were assessed using MTT and wound healing assays. Gene-expression analysis was performed using RNAseq. Results We examined the presence of this SNP in various malignancies, using the entire database of FoundationOne and noted enrichment of it in a subset of pancreatic non-ductal adenocarcinoma (n = 2800) compared to pancreatic ductal adenocarcinoma (PDAC) as well as other tumor types (0.53% vs 0.29%, p = 0.02). Studies in breast and pancreatic cancer cells indicated cell type-dependent activity of ESR1 harboring R269C. Thus, expression of R269C-ESR1 enhanced proliferation and migration of PANC-1 and COLO-357 pancreatic cancer cells but not of MCF-7 breast cancer cells. Moreover, R269C-ESR1 enhanced E2-response elements (ERE) and AP1-dependent transcriptional activity and increased mRNA levels of ERE and AP1-regulated genes in pancreatic cancer cell lines, but had a modest effect on MCF-7 breast cancer cells. Accordingly, whole transcriptome analysis indicated alterations of genes associated with tumorigenicity in pancreatic cancer cells and upregulation of genes associated with cell metabolism and hormone biosynthesis in breast cancer cells. Conclusions Our study shed new light on the role of the hinge region in regulating transcriptional activity of the ER and indicates cell-type specific activity, namely increased activity in pancreatic cancer cells but reduced activity in breast cancer cells. While rare, the presence of rs142712646 may serve as a novel genetic risk factor, and a possible target for therapy in a subset of non-ductal pancreatic cancers. |
topic |
Pancreatic cancer Estrogen receptor Activation Function-1 SNP |
url |
http://link.springer.com/article/10.1186/s12885-020-07005-x |
work_keys_str_mv |
AT tomerboldes r269cvariantofesr1highprevalenceanddifferentialfunctioninasubsetofpancreaticcancers AT kerenmerenbakhlamin r269cvariantofesr1highprevalenceanddifferentialfunctioninasubsetofpancreaticcancers AT shanijourno r269cvariantofesr1highprevalenceanddifferentialfunctioninasubsetofpancreaticcancers AT eliyashachar r269cvariantofesr1highprevalenceanddifferentialfunctioninasubsetofpancreaticcancers AT doronlipson r269cvariantofesr1highprevalenceanddifferentialfunctioninasubsetofpancreaticcancers AT advayeheskel r269cvariantofesr1highprevalenceanddifferentialfunctioninasubsetofpancreaticcancers AT metsadapasmanikchor r269cvariantofesr1highprevalenceanddifferentialfunctioninasubsetofpancreaticcancers AT tamirubinek r269cvariantofesr1highprevalenceanddifferentialfunctioninasubsetofpancreaticcancers AT idowolf r269cvariantofesr1highprevalenceanddifferentialfunctioninasubsetofpancreaticcancers |
_version_ |
1724542261890383872 |